WO2004019791A2 - Device for closure of a vascular defect and method for treating the same - Google Patents

Device for closure of a vascular defect and method for treating the same Download PDF

Info

Publication number
WO2004019791A2
WO2004019791A2 PCT/US2003/024764 US0324764W WO2004019791A2 WO 2004019791 A2 WO2004019791 A2 WO 2004019791A2 US 0324764 W US0324764 W US 0324764W WO 2004019791 A2 WO2004019791 A2 WO 2004019791A2
Authority
WO
WIPO (PCT)
Prior art keywords
occlusive
vaso
support structure
stent
securement member
Prior art date
Application number
PCT/US2003/024764
Other languages
French (fr)
Other versions
WO2004019791A3 (en
Inventor
Stephen Porter
Original Assignee
Scimed Life Systems, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scimed Life Systems, Inc. filed Critical Scimed Life Systems, Inc.
Priority to AU2003256880A priority Critical patent/AU2003256880A1/en
Priority to EP03791657A priority patent/EP1549229B1/en
Priority to CA002485206A priority patent/CA2485206A1/en
Priority to JP2004532875A priority patent/JP4472525B2/en
Priority to DE60326474T priority patent/DE60326474D1/en
Publication of WO2004019791A2 publication Critical patent/WO2004019791A2/en
Publication of WO2004019791A3 publication Critical patent/WO2004019791A3/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12099Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder
    • A61B17/12109Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel
    • A61B17/12113Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel within an aneurysm
    • A61B17/12118Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel within an aneurysm for positioning in conjunction with a stent
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12131Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
    • A61B17/12168Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device having a mesh structure
    • A61B17/12172Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device having a mesh structure having a pre-set deployed three-dimensional shape
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12131Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
    • A61B17/12181Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device formed by fluidized, gelatinous or cellular remodelable materials, e.g. embolic liquids, foams or extracellular matrices
    • A61B17/1219Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device formed by fluidized, gelatinous or cellular remodelable materials, e.g. embolic liquids, foams or extracellular matrices expandable in contact with liquids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • A61B2017/1205Introduction devices

Definitions

  • the present invention relates generally to implantable devices and methods for the treatment of vascular defects.
  • vascular stent for example. Stents may be employed to prop up vessel walls and maintain openings in vessels in the coronary system, the brain, the urinary, biliary, esophageal, tracheal and bronchial tracts, and so forth.
  • aneurysm which is an area of a weakened vessel wall that causes a bulge or bubble to protrude out in a radial direction from the adjacent vessel. If untreated, an aneurysm may continue expanding until it bursts, causing hemorrhage. It is therefore often desirable to block fluid flow to the aneurysm.
  • vaso-occlusive devices used for the treatment of such defects may be referred to as vaso-occlusive devices and are commonly deployed to the aneurysm site through the use of a catheter device.
  • Vaso-occlusive devices can have a variety of configurations, and are generally formed of one or more elements that have a deployed configuration for blocking blood flow which is different from their configuration during delivery to the site.
  • Devices for bridging the necks of wide-necked or narrow-necked aneurysms are found, for example, in US 5935148, US 6063070, US 6036720, US 6063104 and US 6139564. These devices may also be used to stabilize the placement of vaso-occlusive devices such as helically wound coils in the aneurysm or may be used to, at least partially, close the aneurysm neck.
  • the aneurysm neck bridge or retainer assemblies described in the patents above may be delivered to the aneurysm in a variety of different ways, but preferably are attached to an electrolytically severable joint for their deployment.
  • the aneurysm After deployment of the neck bridge or retainer, the aneurysm is at least partially filled with a vaso-occlusive device such as a helically wound coil.
  • a vaso-occlusive device such as a helically wound coil.
  • the vaso-occlusive devices may also be delivered to the aneurysm using a number of different methods such as by a core wire which is linked to the coils by an electrolytically severable joint or a mechanically severable joint.
  • the vaso-occlusive devices may also be simply pushed into the aneurysm. The success of such devices as those described above, may depend on several factors, however, including whether or not the device can migrate out of the aneurysm through the neck of the aneurysm.
  • a vaso-occlusive device applicable to the treatment of an aneurysm is a covered stent or a stent-graft.
  • Covered stents have a limited usefulness due to the stiffness of the device, and synthetic grafts themselves have a tendency to occlude when employed in small blood vessels.
  • Arteries where there is an aneurysm typically have a lot of branching, and when employing a covered stent, there is a further risk of occluding the small branch vessels airising from the parent artery rather than simply blocking the neck of the aneurysm as desired.
  • vaso-occlusive device that can be delivered to an aneurysm or other body vessel in a primary unexpanded configuration, wherein such device can be deployed and released to assume a secondary, expanded configuration which occludes the neck of the aneurysm, and which can be anchored at the site of the aneurysm so that it does not migrate from the site.
  • the present invention relates generally to a vaso-occlusive device which is adapted to be inserted into a portion of a vasculature for treatment of a body vessel such as an aneurysm, and to methods of using the device.
  • the vaso-occlusive device of the present invention is generally employed in combination with a support structure such as a stent, stent-graft, and the like.
  • the device is designed in such a way that it may be readily anchored at the site of the vascular defect to prevent migration of the device.
  • more than one support structure may be employed in a given procedure as well.
  • the vaso-occlusive device of the present invention includes at least one occlusive member having a first unexpanded configuration and a second expanded configuration, and at least one securement member for securing the device to a stent, stent-graft, or the like, in order to prevent migration of the fluid flow- occluding device from the site of the vascular defect.
  • the device is retained within or as a part of a microcatheter system in an unexpanded configuration to cross the neck of the aneurysm, and then once across the neck, the device may be allowed to expand by pulling back the microcatheter, pulling back a shaft about the microcatheter, or by employing a pusher device.
  • the device may be formed of a variety of materials including, but not limited to flexible polymeric materials and metallic materials including shape memory materials, superelastic materials, compressed foams, swellable materials, braided or woven materials and meshes formed from both polymeric materials and shape memory alloys, for example, and so forth.
  • the materials are biocompatible.
  • Bioactive materials or materials having incorporated bioactive agents may also be employed in the construction of the device according to the present invention.
  • the device may be employed in minimally invasive, interventional procedures for the treatment of a vascular defect where it is desirable to block the flow of fluid, if not completely then to a substantial degree, into the defective area of the vessel.
  • the method includes deploying a support structure to the site of the vascular defect, deploying the vaso-occlusive device to the site of the vascular defect, inserting the vaso-occlusive device into the vascular defect through an opening in the support structure, deploying at least one occlusive member, and deploying at least one securement member.
  • both the support structure and the vaso-occlusive device are deployed using a catheter.
  • Fig. 1 illustrates one embodiment of a vaso-occlusive device according to the present invention.
  • Fig. 2 is a depiction of a stent located in a blood vessel at the site of an aneurysm prior to deployment of a vaso-occlusive device according to the present invention.
  • Fig. 3 illustrates initial delivery of a catheter device with the vaso- occlusive device of the present invention retained therein.
  • Fig. 4 illustrates initial deployment of the vaso-occlusive device released from the catheter but in an unexpanded state.
  • Fig. 5 illustrates one embodiment of the occlusive member of the vaso-occlusive device of the present invention in an expanded state.
  • Fig. 6 illustrates one embodiment of the vaso-occlusive device of the present invention positioned at the neck of an aneurysm.
  • Fig. 7 illustrates one embodiment of the vaso-occlusive device of the present invention in an expanded state with the securement member released and in position.
  • Fig. 8 illustrates a vaso-occlusive device according to the present invention, in combination with a catheter delivery device.
  • Fig. 9 illustrates the device of Fig. 8 during deployment.
  • Fig. 10 illustrates the vaso-occlusive device of Fig. 8 after deployment.
  • Fig. 11 is an expanded view of one embodiment of the securement member prior to deployment.
  • Fig. 12 is an expanded view of the same securement member as in Fig. 11 but in a deployed configuration.
  • Fig. 13 illustrates an alternative embodiment of the securement member of the vaso-occlusive device of the present invention prior to release from the catheter.
  • Fig. 14 illustrates the same securement member as shown in Fig. 13, but after release from the catheter.
  • Fig. 15 illustrates another alternative embodiment wherein both the occlusive member and the securement member are formed of the same material.
  • Fig.16 illustrates the same device as shown in Fig. 15 with both the occlusive member and the securement member deployed.
  • Fig. 17 illustrates a specialized opening which may be formed in a stent for accepting the vaso-occlusive device.
  • Fig. 1 illustrates generally at 100, one embodiment of the vaso-occlusive device according to the present invention in which the occlusive member 20 is in a fully expanded form, but the securement member 30 has not yet been released from the catheter 50. The top of the securement member 30 is visible. A pusher wire 22 is shown disposed within the catheter lumen.
  • junction 40 for severing the connection between a catheter delivery device 50 and the vaso-occlusive device 100 after deployment of vaso-occlusive device 100.
  • Junction 40 may be severed using any of a variety of different methods including, but not limited to, electrolytic corrosion, mechanical actuation, hydraulic pressure, thermal processes, electromagnetic energy, and so forth as described above. Other methods of detachment known to those of skill in the art but not described herein may also be employed in releasing the device of the present invention.
  • Severable junctions which may be employed in the present invention are described, for example, in US 5122136, US 5354295, US 5540680, US 5855578, US 5895385, US 5925037, US 5944714, US 5947963, US 5976126, US 6010498, US 6066133 and US 6083220, each of which is incorporated by reference herein in its entirety.
  • Figs. 2-7 illustrate a series of steps involved in the deployment of the vaso-occlusive device 100 according to the present invention.
  • a support structure in this embodiment a stent 10, is shown deployed within a blood vessel 12 at the site of a vessel defect or aneurysm 14 and located at the opening or neck 19 of the aneurysm 14.
  • the stent 10 has a plurality of stent struts 15 having openings 17 therebetween.
  • Stent 10 is in its expanded configuration within blood vessel 12.
  • An occlusive device according to the present invention may be formed and configured such that it may be deployed through the openings 17 between struts 15.
  • FIG. 3 illustrates the initial delivery of one embodiment of the device of the present invention (not visible in Fig. 2) in an unexpanded state through the use of a microcatheter device 50, such as a microcatheter.
  • the microcatheter 50 is guided through blood vessel 12 and through stent 10 and is then threaded through an opening 17 located between stent struts 15 and into the aneurysm 14.
  • the vaso- occlusive device 10 (not shown) may be rolled, compressed or otherwise unexpanded into a form that can be pushed through and retained in microcatheter 50.
  • Fig. 3 illustrates the initial delivery of one embodiment of the device of the present invention (not visible in Fig. 2) in an unexpanded state through the use of a microcatheter device 50, such as a microcatheter.
  • the microcatheter 50 is guided through blood vessel 12 and through stent 10 and is then threaded through an opening 17 located between stent struts 15 and
  • the microcatheter 50 can be seen shown disposed within stent 10 in blood vessel 12 and projecting upward through opening 17 formed by struts 15 and into aneurysm 14.
  • the securement member 30 can be seen at the distal tip 55 of microcatheter 50.
  • vaso-occlusive device 100 is shown in the initial stage of being released from microcatheter 50 by use of a pusher wire 22 (not shown).
  • the occlusive member 20 is still in an unexpanded configuration.
  • the securement member 30 is also in its unexpanded configuration.
  • Reference numeral 40 represents a detachable or severable junction which can be severed using a number of different mechanisms including, but not limited to, electrolytic corrosion, mechanical actuation, hydraulic pressure, thermal processes, electromagnetic energy, and so forth as described above. It is at this junction 40 that the vaso-occlusive device 100 is eventually detached from pusher wire 22 (not shown) which is disposed inside microcatheter 50. Other methods of detachment not described herein, but known in the art, may also be employed in detaching the device of the present invention.
  • occlusive member 20 Upon release from microcatheter 50, occlusive member 20 expands as shown in Fig. 5. Occlusive member 20 may be made expandable upon release using any number of methods known in the art. For example, shape memory materials including both polymeric and metallic materials may be employed, materials which are swellable in an aqueous environment may be employed, compressed foams, braided, woven, knit, felt-like materials, meshes, and so forth, may also be employed. In this particular embodiment, occlusive member 20 is shown in an umbrella-like form.
  • occlusive member 20 may be in the form of a disc, parabola, sphere, or the like providing that it is of a configuration to block or bridge the neck 19 of aneurysm 14 so that no fluid, or substantially no fluid, may flow between vessel 12 and aneurysm 14. Suitable materials for formation of such an occlusive member include flexible polymeric materials, for example. Securement member 30, is also not yet in its deployed configuration. Occlusive member 20 is then pulled back until it comes in contact with stent 10 and is now blocking the opening or neck 19 of aneurysm 14 as shown in Fig. 6.
  • securement member 30 is at least partially protruding through the opposite side of the stent struts 15 as the occlusive member 20, and is still in an unexpanded configuration.
  • the securement member 30 is then released by pulling back on the catheter device 50 while maintaining the position of the pusher wire 22 as shown in Fig. 7.
  • the securement member 30 upon release from the catheter device 50 expands.
  • securement member 30 anchors the vaso- occlusive device 100 to the stent 10.
  • the securement member 30 is located on the opposite side of the stent struts 15 as the occlusive member 20. Securement member 30 may operate in one of several different ways.
  • the securement member 30 operates by either expanding to the point at which it may no longer fit back through the opening 17 between stent struts 15 through which it initially came, or it may be constructed of a shape memory material, for example, that remains inside the microcatheter 50 until deployment of the occlusive member 20. Thus, it does not deploy until the occlusive member 20 is deployed.
  • Fig. 7 the microcatheter 50 is shown being drawn away from the vaso-occlusive device, releasing the securement member 30 which then lays open and flat against the stent struts 15.
  • the securement member 30 extends through and is located on the opposite side of the occlusive member 20 and effectively anchors the vaso-occlusive device 100 into position.
  • Fig. 8 illustrates generally at 110 a catheter delivery device having a vaso-occlusive device 100 disposed inside a retractable sheath 116 at the distal end 112 of the catheter delivery device 110.
  • the catheter device has a tubular support structure 114.
  • a guidewire 75 is first positioned inside the vasculature.
  • the catheter delivery device 1 10 is then maneuvered through the vasculature over the guidewire 75 to the site of the vascular defect (not shown) wherein a support structure such as a stent, has already been positioned.
  • the catheter delivery device 110 is then maneuvered between struts 15 of the stent structure and is positioned in the vascular defect (not shown).
  • the catheter delivery device 110 is shown positioned between two struts 15. The vaso-occlusive device is not yet deployed.
  • Fig. 9 the retractable sheath 116 is shown in a partially pulled back position releasing the occlusive member 20 of the vaso-occlusive device 100.
  • the vaso-occlusive device 100 as shown in Figs. 8-10 illustrates an embodiment of the vaso-occlusive device in which the occlusive member 20 has a frame 118 which in its unexpanded state as shown in Fig. 8 and in an expanded state as shown in Fig. 10, is similar to an umbrella.
  • the frame 118 has individual spokes 120 which in the expanded state support the canopy 122 of the umbrella- like structure.
  • Fig. 11 illustrates one embodiment of the securement member 30 of the vaso-occlusive device of the present invention in which securement member 30 is formed from a swellable material such as a hydrogel which swells upon exposure to an aqueous environment, or one with memory such as a compressed foam wherein the material returns to its original shape upon release from the microcatheter 50.
  • securement member 30 is shown just released from microcatheter 50 and is not yet in its expanded configuration.
  • Struts 15 are shown on either side of the securement member 30.
  • Fig. 12 illustrates the same securement member 30 as in Fig. 11, but in a deployed configuration.
  • Struts 15, are now located between occlusive member 20, which is now in an expanded configuration, and securement member 30, which is also in a deployed configuration.
  • Fig. 12 shows the securement member 30 wherein it is anchored to the stent by "wrapping" itself around the stents struts 15 in its deployed state.
  • Occlusive member 20 may also be formed from the same swellable material, or the same material having memory as securement member 30. It may also be formed of a different material.
  • Fig. 13 illustrates an alternative embodiment of the vaso-occlusive device of the present invention in which the securement member 30 is formed from strut-like elements 60 which are held inside microcatheter 50.
  • the struts 15 may be leaf shaped (as shown) on a flattened helical form, or may be any shape which can be compressed to fit within a microcatheter and can expand to a shape which cannot fit through the openings in the strut 15.
  • strut-like elements 60 of securement member 30 may be formed of a shape memory material such as NITINOL®, or may be formed from a superelastic material.
  • a severable junction 40 which is described above. Severable junction 40, in this embodiment, is shown in contact with occlusive member 20, as opposed to the embodiment shown in Figs. 11 and 12, in which severable junction 40, is shown in contact with securement member 30.
  • Fig. 15 illustrates an embodiment of the vaso-occlusive device of the present invention in which both the occlusive member 20 and the securement member 30 are formed from a single material.
  • a material which swells upon exposure to an aqueous environment include, for example, hydrogels, compressed foams, or the like. Swellable materials are discussed in more detail below.
  • both the occlusive member 20 and the securement member 30 have been released using the pusher wire, and they begin to swell.
  • the vaso-occlusive device 100 is then brought down into the neck of the aneurysm such that the securement member 30 is on the opposite side of the stent struts 15 from the occlusive member 20.
  • the securement member 30 is on one side of the struts 15 and the occlusive member 20 is on the opposite side and actually in the aneurysm (not shown). In this manner, the securement member 30 anchors the vaso-occlusive device 100 to the stent.
  • the stent may be made with a specialized opening 70 for accepting the vaso- occlusive device 100 of the present invention as shown in Fig. 17.
  • a severable junction 40 is shown for detaching vaso-occlusive device 100 from catheter delivery device 50.
  • securement members While in the embodiments described above, only one securement member has been employed in each embodiment, one or more securement members may be employed in the present invention. Securement members of any shape may be employed.
  • support structures of any shape may be employed.
  • linear, Y-shaped, T-shaped stents, and so forth may be employed.
  • the occlusive portion of the device according to the present invention may be manufactured from any of a variety of materials including, but not limited to, polymeric materials.
  • useful polymeric materials include both synthetic and natural materials. Further, the materials may be biocompatible and/or biodegradable materials.
  • useful polymer materials include, but are not limited to, polyolefins including polyethylene and polypropylene, polyesters such as polyethyleneterephthalate(PET) and polybutylene terephthalate (PBT), polyurethanes, acrylics, polypeptides, polyethers, polyamides, fluoropolymers such as expanded polytetrafluoroethylene, and so on and so forth.
  • Swellable polymeric materials find utility herein. Such materials include those which are known to expand and become lubricious in aqueous fluids including, for example, a class of materials referred to generally as hydrogels may also be employed in the manufacture of the device according to the present invention. Such materials include hydrophilic, macroporous, polymeric, hydrogel foam material.
  • Such materials include, but are not limited, polyvinylpyrrolindone, polyethylene oxide and its copolymers with polypropylene oxide, polyacrylic acids, polyvinyl alcohols, hyaluronic acid, heparin, chondroitin sulfate, pectinic acid, carboxyl-derivatized polysaccharides, polyhydroxy ethyl methacrylate, polyacrylamide, hydrolyzed polyacrylonitriles, polymethacrylic acid, polyethylene amines, polysaccharides, and copolymers and combinations thereof, and so forth.
  • polyvinylpyrrolindone polyethylene oxide and its copolymers with polypropylene oxide
  • polyacrylic acids polyvinyl alcohols, hyaluronic acid, heparin, chondroitin sulfate, pectinic acid, carboxyl-derivatized polysaccharides, polyhydroxy ethyl methacrylate, polyacrylamide, hydrolyzed poly
  • a swellable material includes a swellable foam matrix formed as a macroporous solid is described in US 5750585 which is incorporated by reference herein in its entirety.
  • This material includes a foam stabilizing agent and a polymer or copolymer of a free radical polymerizable hydrophilic olefm monomer cross-linked with up to about 10% by weight of a multiolefin-functional cross-linking agent.
  • Shape memory materials are suitable for use in formation of the vaso- occlusive device of the present invention.
  • Shape memory materials may be polymeric or metallic. Shape memory materials have the ability to remember their original shape, either after mechanical deformation, or by cooling and heating. Such materials are said to undergo a structural phase transformation.
  • shape memory polymers SMPs are found to be segregated linear block co-polymers having a hard segment and a soft segment wherein the hard segment is crystalline, with a defined melting point, and the soft segment is amorphous, with a defined glass transition temperature.
  • the hard segment may be amorphous and have a glass transition temperature rather than a melting point
  • the soft segment may be crystalline and have a melting point rather than a glass transition temperature.
  • the melting point or glass transition temperature of the soft segment is substantially less than the melting point or glass transition temperature of the hard segment.
  • shape memory polymers include, but are not limited to, those formed from polyethers, polyacrylates, polyamides, polysiloxanes, polyurethanes, polyether amides, polyurethane/ureas, polyether esters, urethane/butadiene copolymers, polynorbornenes, and mixtures thereof. See, for example, US 5506300, US 5145935, US 5665822, and US 6388043 each of which is incorporated by reference herein in its entirety.
  • Shape memory metals suitable for use herein include the alloys of TiNi (NITINOL®), CuZnAl, and FeNiAl, for example. These materials undergo a structure phase transformation referred to as a martensitic transformation.
  • Compressed foams may also be employed in the present invention because they have the ability to return to their original shape. Both open and closed cell foams may be employed. Materials satisfactory for use in compressed foams include, but are not limited to medical grade silicones and polyurethanes. As described above, natural materials such as collagens, may also be employed to make a compressed foam material. Bioactive materials or materials having incorporated bioactive agents which facilitate aneurysm healing may also be employed in the construction of the device. Bioactive materials include agents which illicit a biological response within a patient. Such bioactive include therapeutic agents and drugs, for example. These agents may promote healing, tissue growth, cell growth, and so forth.
  • the vaso-occlusive device in particular, the occlusive member, may be formed with a braided, woven, or mesh configuration.
  • Copolymers, and crosslinkable versions of the above described materials may also be suitable for use herein. And, of course, mixtures of the various materials described above may also be employed in the manufacture of the device according to the present invention.
  • the occlusive member may be formed of a combination of at least one polymeric material and at least one metal.
  • a metallic material such as a shape memory alloy, is employed to form the strut parts of an umbrella like structure which has an occlusive member similar to the canopy of an umbrella, and further has a frame including a plurality of spokes for providing support to the canopy.
  • the canopy is formed of a polymeric material while the frame may be formed a metallic material or a polymeric material, for example.
  • the frame and canopy have an expanded configuration and an unexpanded configuration for delivery.
  • the material from which the vaso-occlusive device is formed, or the vaso-occlusive device itself may be modified, or provided with additives, to make the vaso-occlusive device visible by conventional imaging techniques.
  • the device may be rendered visible using fluoroscopic techniques, rendered MRI visible, or both. This can be accomplished through the use of markers such as wire windings, marker bands, rivets, plugs, and so forth, or the radiopaque or MRI visible materials may be incorporated into the material from which the vaso-occlusive device is formed. Any suitable radiopaque or MRI visible material may be employed.
  • Suitable materials for providing radiopacity to the device include, but are not limited to, platinum, rhodium, palladium, rhenium, iridium, tantalum, tungsten, gold, silver, alloys of these metals, as well as polymeric materials with barium, for example. Radiopacity is desirable for visualization of the device for purposes of positioning the device at the site of the defect and to position inside the defect and for proper anchoring of the device.
  • the invention is further directed to the combination of a vaso- occlusive device having at least one securement member and a stent, where the at least one securement member is secured to the stent. Also, the invention is directed to the combination of a delivery catheter and a vaso-occlusive device having at least one securement member.
  • the invention is further directed to a method of occluding a vascular defect having an opening.
  • the method comprises the steps of: a) deploying a support structure, as discussed above, to the vascular defect, the support structure having an opening for accepting a vaso-occlusive device; b) deploying a vaso-occlusive device having at least one occlusive member having an expanded configuration and an unexpanded configuration, as discussed above and at least one securement member, as discussed above, through the opening of the support structure and through the opening of the vascular defect into the vascular defect; c) expanding the at least one occlusive member; and d) anchoring the vaso-occlusive device to the support structure with the at least one securement member.
  • the invention is also directed to a method of closing and occluding an opening of an aneurysm from a parent blood vessel.
  • the method comprises the steps of: a) deploying a support structure, as discussed above, at the site of the aneurysm, the support structure having at least one opening for accepting a vaso- occlusive device as discussed above, the vaso-occlusive device having at least one occlusive member which has an unexpanded configuration and an expanded configuration and at least one securement member, the support structure positioned at the opening of the aneurysm such that the at least one opening of the support structure is aligned with the opening of the aneurysm; b) deploying the vaso-occlusive device wherein the at least one occlusive member is in its unexpanded configuration, through the at least one opening of the support structure and the opening of the aneurysm and into the aneurysm; c) expanding the at least one occlusive member of the vas

Abstract

A device for the non-invasive treatment of a vascular defect. The device includes at least one occlusive member having a first unexpanded configuration and a second expanded configuration and at least one securement member for securing the vaso-occlusive device to a support structure at the location of the vascular defect.

Description

DEVICE FOR CLOSURE OF A VASCULAR DEFECT
AND METHOD FOR TREATING THE SAME
FIELD OF THE INVENTION
The present invention relates generally to implantable devices and methods for the treatment of vascular defects.
BACKGROUND OF THE INVENTION
Many minimally invasive or noninvasive interventional medical devices and procedures have been used to treat defects in the vasculature which are not easily reached by surgical procedures. Such medical devices which are adapted for implantation in body lumens in order to support weakened or occluded vessel walls and allow fluid flow are well known and commercially available. One such device is a vascular stent, for example. Stents may be employed to prop up vessel walls and maintain openings in vessels in the coronary system, the brain, the urinary, biliary, esophageal, tracheal and bronchial tracts, and so forth.
However, in some situations, it is desirable to block fluid flow. For example, one serious defect in the vascular system is an aneurysm which is an area of a weakened vessel wall that causes a bulge or bubble to protrude out in a radial direction from the adjacent vessel. If untreated, an aneurysm may continue expanding until it bursts, causing hemorrhage. It is therefore often desirable to block fluid flow to the aneurysm.
Devices used for the treatment of such defects may be referred to as vaso-occlusive devices and are commonly deployed to the aneurysm site through the use of a catheter device. Vaso-occlusive devices can have a variety of configurations, and are generally formed of one or more elements that have a deployed configuration for blocking blood flow which is different from their configuration during delivery to the site.
Devices for bridging the necks of wide-necked or narrow-necked aneurysms are found, for example, in US 5935148, US 6063070, US 6036720, US 6063104 and US 6139564. These devices may also be used to stabilize the placement of vaso-occlusive devices such as helically wound coils in the aneurysm or may be used to, at least partially, close the aneurysm neck. The aneurysm neck bridge or retainer assemblies described in the patents above may be delivered to the aneurysm in a variety of different ways, but preferably are attached to an electrolytically severable joint for their deployment. After deployment of the neck bridge or retainer, the aneurysm is at least partially filled with a vaso-occlusive device such as a helically wound coil. The vaso-occlusive devices may also be delivered to the aneurysm using a number of different methods such as by a core wire which is linked to the coils by an electrolytically severable joint or a mechanically severable joint. The vaso-occlusive devices may also be simply pushed into the aneurysm. The success of such devices as those described above, may depend on several factors, however, including whether or not the device can migrate out of the aneurysm through the neck of the aneurysm. Another example of a vaso-occlusive device applicable to the treatment of an aneurysm is a covered stent or a stent-graft. Covered stents have a limited usefulness due to the stiffness of the device, and synthetic grafts themselves have a tendency to occlude when employed in small blood vessels. Arteries where there is an aneurysm typically have a lot of branching, and when employing a covered stent, there is a further risk of occluding the small branch vessels airising from the parent artery rather than simply blocking the neck of the aneurysm as desired.
Thus, it would be beneficial to have a vaso-occlusive device that can be delivered to an aneurysm or other body vessel in a primary unexpanded configuration, wherein such device can be deployed and released to assume a secondary, expanded configuration which occludes the neck of the aneurysm, and which can be anchored at the site of the aneurysm so that it does not migrate from the site.
SUMMARY OF THE INVENTION
The present invention relates generally to a vaso-occlusive device which is adapted to be inserted into a portion of a vasculature for treatment of a body vessel such as an aneurysm, and to methods of using the device. The vaso-occlusive device of the present invention is generally employed in combination with a support structure such as a stent, stent-graft, and the like. The device is designed in such a way that it may be readily anchored at the site of the vascular defect to prevent migration of the device. Of course, more than one support structure may be employed in a given procedure as well. The vaso-occlusive device of the present invention includes at least one occlusive member having a first unexpanded configuration and a second expanded configuration, and at least one securement member for securing the device to a stent, stent-graft, or the like, in order to prevent migration of the fluid flow- occluding device from the site of the vascular defect. The device is retained within or as a part of a microcatheter system in an unexpanded configuration to cross the neck of the aneurysm, and then once across the neck, the device may be allowed to expand by pulling back the microcatheter, pulling back a shaft about the microcatheter, or by employing a pusher device.
The device may be formed of a variety of materials including, but not limited to flexible polymeric materials and metallic materials including shape memory materials, superelastic materials, compressed foams, swellable materials, braided or woven materials and meshes formed from both polymeric materials and shape memory alloys, for example, and so forth. Suitably, the materials are biocompatible. Bioactive materials or materials having incorporated bioactive agents may also be employed in the construction of the device according to the present invention.
The device may be employed in minimally invasive, interventional procedures for the treatment of a vascular defect where it is desirable to block the flow of fluid, if not completely then to a substantial degree, into the defective area of the vessel.
In one embodiment, the method includes deploying a support structure to the site of the vascular defect, deploying the vaso-occlusive device to the site of the vascular defect, inserting the vaso-occlusive device into the vascular defect through an opening in the support structure, deploying at least one occlusive member, and deploying at least one securement member.
Suitably, both the support structure and the vaso-occlusive device are deployed using a catheter.
These and other aspects and advantages of the invention will become apparent from the following detailed description and the accompanying drawings, which illustrate by way of example the features of the invention. BRIEF DESCRIPTION OF THE DRAWINGS
Fig. 1 illustrates one embodiment of a vaso-occlusive device according to the present invention.
Fig. 2 is a depiction of a stent located in a blood vessel at the site of an aneurysm prior to deployment of a vaso-occlusive device according to the present invention.
Fig. 3 illustrates initial delivery of a catheter device with the vaso- occlusive device of the present invention retained therein.
Fig. 4 illustrates initial deployment of the vaso-occlusive device released from the catheter but in an unexpanded state. Fig. 5 illustrates one embodiment of the occlusive member of the vaso-occlusive device of the present invention in an expanded state.
Fig. 6 illustrates one embodiment of the vaso-occlusive device of the present invention positioned at the neck of an aneurysm.
Fig. 7 illustrates one embodiment of the vaso-occlusive device of the present invention in an expanded state with the securement member released and in position.
Fig. 8 illustrates a vaso-occlusive device according to the present invention, in combination with a catheter delivery device.
Fig. 9 illustrates the device of Fig. 8 during deployment. Fig. 10 illustrates the vaso-occlusive device of Fig. 8 after deployment.
Fig. 11 is an expanded view of one embodiment of the securement member prior to deployment.
Fig. 12 is an expanded view of the same securement member as in Fig. 11 but in a deployed configuration.
Fig. 13 illustrates an alternative embodiment of the securement member of the vaso-occlusive device of the present invention prior to release from the catheter.
Fig. 14 illustrates the same securement member as shown in Fig. 13, but after release from the catheter.
Fig. 15 illustrates another alternative embodiment wherein both the occlusive member and the securement member are formed of the same material. Fig.16 illustrates the same device as shown in Fig. 15 with both the occlusive member and the securement member deployed.
Fig. 17 illustrates a specialized opening which may be formed in a stent for accepting the vaso-occlusive device.
DETAILED DESCRIPTIONS OF THE PREFERRED EMBODIMENTS
While this invention may be embodied in many different forms, there are described in detail herein specific embodiments of the invention. This description is an exemplification of the principles of the invention and is not intended to limit the invention to the particular embodiments illustrated. Turning now to the figures, Fig. 1 illustrates generally at 100, one embodiment of the vaso-occlusive device according to the present invention in which the occlusive member 20 is in a fully expanded form, but the securement member 30 has not yet been released from the catheter 50. The top of the securement member 30 is visible. A pusher wire 22 is shown disposed within the catheter lumen.
Also seen in Fig. 1 is a severable junction 40 for severing the connection between a catheter delivery device 50 and the vaso-occlusive device 100 after deployment of vaso-occlusive device 100. Junction 40 may be severed using any of a variety of different methods including, but not limited to, electrolytic corrosion, mechanical actuation, hydraulic pressure, thermal processes, electromagnetic energy, and so forth as described above. Other methods of detachment known to those of skill in the art but not described herein may also be employed in releasing the device of the present invention. Severable junctions which may be employed in the present invention are described, for example, in US 5122136, US 5354295, US 5540680, US 5855578, US 5895385, US 5925037, US 5944714, US 5947963, US 5976126, US 6010498, US 6066133 and US 6083220, each of which is incorporated by reference herein in its entirety.
Figs. 2-7 illustrate a series of steps involved in the deployment of the vaso-occlusive device 100 according to the present invention. Beginning with Fig. 2, a support structure, in this embodiment a stent 10, is shown deployed within a blood vessel 12 at the site of a vessel defect or aneurysm 14 and located at the opening or neck 19 of the aneurysm 14. The stent 10 has a plurality of stent struts 15 having openings 17 therebetween. Stent 10 is in its expanded configuration within blood vessel 12. An occlusive device according to the present invention may be formed and configured such that it may be deployed through the openings 17 between struts 15.
While the above stent is shown for illustrative purposes only, it is important to note that any stent design may be employed herein. Fig. 3 illustrates the initial delivery of one embodiment of the device of the present invention (not visible in Fig. 2) in an unexpanded state through the use of a microcatheter device 50, such as a microcatheter. The microcatheter 50 is guided through blood vessel 12 and through stent 10 and is then threaded through an opening 17 located between stent struts 15 and into the aneurysm 14. The vaso- occlusive device 10 (not shown) may be rolled, compressed or otherwise unexpanded into a form that can be pushed through and retained in microcatheter 50. In Fig. 4, the microcatheter 50 can be seen shown disposed within stent 10 in blood vessel 12 and projecting upward through opening 17 formed by struts 15 and into aneurysm 14. The securement member 30 can be seen at the distal tip 55 of microcatheter 50.
In Fig. 4, vaso-occlusive device 100 is shown in the initial stage of being released from microcatheter 50 by use of a pusher wire 22 (not shown). The occlusive member 20 is still in an unexpanded configuration. The securement member 30 is also in its unexpanded configuration. Reference numeral 40 represents a detachable or severable junction which can be severed using a number of different mechanisms including, but not limited to, electrolytic corrosion, mechanical actuation, hydraulic pressure, thermal processes, electromagnetic energy, and so forth as described above. It is at this junction 40 that the vaso-occlusive device 100 is eventually detached from pusher wire 22 (not shown) which is disposed inside microcatheter 50. Other methods of detachment not described herein, but known in the art, may also be employed in detaching the device of the present invention.
As noted above, severable junctions are described, for example, in US 5122136, US 5354295, US 5540680, US 5855578, US 5895385, US 5925037, US 5944714, US 5947963, US 5976126, US 6010498, US 6066133 and US 6083220, each of which is incorporated by reference herein in its entirety.
Upon release from microcatheter 50, occlusive member 20 expands as shown in Fig. 5. Occlusive member 20 may be made expandable upon release using any number of methods known in the art. For example, shape memory materials including both polymeric and metallic materials may be employed, materials which are swellable in an aqueous environment may be employed, compressed foams, braided, woven, knit, felt-like materials, meshes, and so forth, may also be employed. In this particular embodiment, occlusive member 20 is shown in an umbrella-like form. However, occlusive member 20 may be in the form of a disc, parabola, sphere, or the like providing that it is of a configuration to block or bridge the neck 19 of aneurysm 14 so that no fluid, or substantially no fluid, may flow between vessel 12 and aneurysm 14. Suitable materials for formation of such an occlusive member include flexible polymeric materials, for example. Securement member 30, is also not yet in its deployed configuration. Occlusive member 20 is then pulled back until it comes in contact with stent 10 and is now blocking the opening or neck 19 of aneurysm 14 as shown in Fig. 6. At this point, securement member 30, is at least partially protruding through the opposite side of the stent struts 15 as the occlusive member 20, and is still in an unexpanded configuration. The securement member 30 is then released by pulling back on the catheter device 50 while maintaining the position of the pusher wire 22 as shown in Fig. 7. The securement member 30 upon release from the catheter device 50 expands. In its expanded configuration, securement member 30 anchors the vaso- occlusive device 100 to the stent 10. The securement member 30 is located on the opposite side of the stent struts 15 as the occlusive member 20. Securement member 30 may operate in one of several different ways. Desirably, the securement member 30 operates by either expanding to the point at which it may no longer fit back through the opening 17 between stent struts 15 through which it initially came, or it may be constructed of a shape memory material, for example, that remains inside the microcatheter 50 until deployment of the occlusive member 20. Thus, it does not deploy until the occlusive member 20 is deployed.
In Fig. 7, the microcatheter 50 is shown being drawn away from the vaso-occlusive device, releasing the securement member 30 which then lays open and flat against the stent struts 15. The securement member 30 extends through and is located on the opposite side of the occlusive member 20 and effectively anchors the vaso-occlusive device 100 into position.
Fig. 8 illustrates generally at 110 a catheter delivery device having a vaso-occlusive device 100 disposed inside a retractable sheath 116 at the distal end 112 of the catheter delivery device 110. The catheter device has a tubular support structure 114. In this embodiment, a guidewire 75 is first positioned inside the vasculature. The catheter delivery device 1 10 is then maneuvered through the vasculature over the guidewire 75 to the site of the vascular defect (not shown) wherein a support structure such as a stent, has already been positioned. The catheter delivery device 110 is then maneuvered between struts 15 of the stent structure and is positioned in the vascular defect (not shown). In Fig. 8, the catheter delivery device 110 is shown positioned between two struts 15. The vaso-occlusive device is not yet deployed.
In Fig. 9, the retractable sheath 116 is shown in a partially pulled back position releasing the occlusive member 20 of the vaso-occlusive device 100.
In Fig. 10, the retractable sheath 116 has been pulled back all the way further releasing the securement member 30 of the vaso-occlusive device 100.
The vaso-occlusive device 100 as shown in Figs. 8-10, illustrates an embodiment of the vaso-occlusive device in which the occlusive member 20 has a frame 118 which in its unexpanded state as shown in Fig. 8 and in an expanded state as shown in Fig. 10, is similar to an umbrella. The frame 118 has individual spokes 120 which in the expanded state support the canopy 122 of the umbrella- like structure.
Fig. 11 illustrates one embodiment of the securement member 30 of the vaso-occlusive device of the present invention in which securement member 30 is formed from a swellable material such as a hydrogel which swells upon exposure to an aqueous environment, or one with memory such as a compressed foam wherein the material returns to its original shape upon release from the microcatheter 50. In Fig. 11, securement member 30 is shown just released from microcatheter 50 and is not yet in its expanded configuration. Struts 15 are shown on either side of the securement member 30. Fig. 12 illustrates the same securement member 30 as in Fig. 11, but in a deployed configuration. Struts 15, are now located between occlusive member 20, which is now in an expanded configuration, and securement member 30, which is also in a deployed configuration. Fig. 12 shows the securement member 30 wherein it is anchored to the stent by "wrapping" itself around the stents struts 15 in its deployed state. Occlusive member 20, may also be formed from the same swellable material, or the same material having memory as securement member 30. It may also be formed of a different material. Fig. 13 illustrates an alternative embodiment of the vaso-occlusive device of the present invention in which the securement member 30 is formed from strut-like elements 60 which are held inside microcatheter 50. The struts 15 may be leaf shaped (as shown) on a flattened helical form, or may be any shape which can be compressed to fit within a microcatheter and can expand to a shape which cannot fit through the openings in the strut 15. When microcatheter 50 is pulled back from stent 10, the strut-like elements 60, are released and open, laying flat against stent struts 15 as shown in Fig. 14. In this embodiment, strut-like elements 60 of securement member 30, may be formed of a shape memory material such as NITINOL®, or may be formed from a superelastic material. Also visible in Fig. 14, is a severable junction 40 which is described above. Severable junction 40, in this embodiment, is shown in contact with occlusive member 20, as opposed to the embodiment shown in Figs. 11 and 12, in which severable junction 40, is shown in contact with securement member 30.
Fig. 15 illustrates an embodiment of the vaso-occlusive device of the present invention in which both the occlusive member 20 and the securement member 30 are formed from a single material. In this embodiment, a material which swells upon exposure to an aqueous environment. Such materials include, for example, hydrogels, compressed foams, or the like. Swellable materials are discussed in more detail below. As shown in Fig. 15, both the occlusive member 20 and the securement member 30 have been released using the pusher wire, and they begin to swell. The vaso-occlusive device 100 is then brought down into the neck of the aneurysm such that the securement member 30 is on the opposite side of the stent struts 15 from the occlusive member 20. The swelling continues and the device blocks the aneurysm. The device is in its fully expanded configuration in Fig. 16. As can be seen from Fig. 16, the securement member 30 is on one side of the struts 15 and the occlusive member 20 is on the opposite side and actually in the aneurysm (not shown). In this manner, the securement member 30 anchors the vaso-occlusive device 100 to the stent.
In another embodiment, rather than deploying the vaso-occlusive device 100 (only shown in partial view) through openings formed between stent struts, the stent may be made with a specialized opening 70 for accepting the vaso- occlusive device 100 of the present invention as shown in Fig. 17. Again, in Figs. 15-17, a severable junction 40 is shown for detaching vaso-occlusive device 100 from catheter delivery device 50.
While in the embodiments described above, only one securement member has been employed in each embodiment, one or more securement members may be employed in the present invention. Securement members of any shape may be employed.
Further, support structures of any shape may be employed. For example, linear, Y-shaped, T-shaped stents, and so forth may be employed.
The occlusive portion of the device according to the present invention may be manufactured from any of a variety of materials including, but not limited to, polymeric materials. Examples of useful polymeric materials include both synthetic and natural materials. Further, the materials may be biocompatible and/or biodegradable materials. Examples of useful polymer materials include, but are not limited to, polyolefins including polyethylene and polypropylene, polyesters such as polyethyleneterephthalate(PET) and polybutylene terephthalate (PBT), polyurethanes, acrylics, polypeptides, polyethers, polyamides, fluoropolymers such as expanded polytetrafluoroethylene, and so on and so forth.
Swellable polymeric materials find utility herein. Such materials include those which are known to expand and become lubricious in aqueous fluids including, for example, a class of materials referred to generally as hydrogels may also be employed in the manufacture of the device according to the present invention. Such materials include hydrophilic, macroporous, polymeric, hydrogel foam material. Examples of such materials include, but are not limited, polyvinylpyrrolindone, polyethylene oxide and its copolymers with polypropylene oxide, polyacrylic acids, polyvinyl alcohols, hyaluronic acid, heparin, chondroitin sulfate, pectinic acid, carboxyl-derivatized polysaccharides, polyhydroxy ethyl methacrylate, polyacrylamide, hydrolyzed polyacrylonitriles, polymethacrylic acid, polyethylene amines, polysaccharides, and copolymers and combinations thereof, and so forth.
One particular example of a swellable material includes a swellable foam matrix formed as a macroporous solid is described in US 5750585 which is incorporated by reference herein in its entirety. This material includes a foam stabilizing agent and a polymer or copolymer of a free radical polymerizable hydrophilic olefm monomer cross-linked with up to about 10% by weight of a multiolefin-functional cross-linking agent.
Naturally based materials or those which are biologically derived which find utility herein include, but are not limited to, collagen foams, harvested vascular material, films constructed from processed tissues, and so forth. Shape memory materials are suitable for use in formation of the vaso- occlusive device of the present invention. Shape memory materials may be polymeric or metallic. Shape memory materials have the ability to remember their original shape, either after mechanical deformation, or by cooling and heating. Such materials are said to undergo a structural phase transformation. Typically, shape memory polymers (SMPs) are found to be segregated linear block co-polymers having a hard segment and a soft segment wherein the hard segment is crystalline, with a defined melting point, and the soft segment is amorphous, with a defined glass transition temperature. However, the hard segment may be amorphous and have a glass transition temperature rather than a melting point, and the soft segment may be crystalline and have a melting point rather than a glass transition temperature. The melting point or glass transition temperature of the soft segment is substantially less than the melting point or glass transition temperature of the hard segment. Some examples of shape memory polymers include, but are not limited to, those formed from polyethers, polyacrylates, polyamides, polysiloxanes, polyurethanes, polyether amides, polyurethane/ureas, polyether esters, urethane/butadiene copolymers, polynorbornenes, and mixtures thereof. See, for example, US 5506300, US 5145935, US 5665822, and US 6388043 each of which is incorporated by reference herein in its entirety.
Shape memory metals suitable for use herein include the alloys of TiNi (NITINOL®), CuZnAl, and FeNiAl, for example. These materials undergo a structure phase transformation referred to as a martensitic transformation.
Compressed foams may also be employed in the present invention because they have the ability to return to their original shape. Both open and closed cell foams may be employed. Materials satisfactory for use in compressed foams include, but are not limited to medical grade silicones and polyurethanes. As described above, natural materials such as collagens, may also be employed to make a compressed foam material. Bioactive materials or materials having incorporated bioactive agents which facilitate aneurysm healing may also be employed in the construction of the device. Bioactive materials include agents which illicit a biological response within a patient. Such bioactive include therapeutic agents and drugs, for example. These agents may promote healing, tissue growth, cell growth, and so forth. The vaso-occlusive device, in particular, the occlusive member, may be formed with a braided, woven, or mesh configuration.
Copolymers, and crosslinkable versions of the above described materials may also be suitable for use herein. And, of course, mixtures of the various materials described above may also be employed in the manufacture of the device according to the present invention.
A single material may be employed in forming both the occlusive member and the securement member, or different materials may be employed as described in some of the embodiments above. Additionally, one or more materials may be employed in forming only the occlusive member and/or the securement member. For example, in a further embodiment, the occlusive member may be formed of a combination of at least one polymeric material and at least one metal. In this embodiment, a metallic material such as a shape memory alloy, is employed to form the strut parts of an umbrella like structure which has an occlusive member similar to the canopy of an umbrella, and further has a frame including a plurality of spokes for providing support to the canopy. The canopy is formed of a polymeric material while the frame may be formed a metallic material or a polymeric material, for example. The frame and canopy have an expanded configuration and an unexpanded configuration for delivery.
The above lists of materials are intended for illustrative purposes only and are by no means exhaustive. One of ordinary skill in the art knows materials of the types described above.
The material from which the vaso-occlusive device is formed, or the vaso-occlusive device itself may be modified, or provided with additives, to make the vaso-occlusive device visible by conventional imaging techniques. For example, the device may be rendered visible using fluoroscopic techniques, rendered MRI visible, or both. This can be accomplished through the use of markers such as wire windings, marker bands, rivets, plugs, and so forth, or the radiopaque or MRI visible materials may be incorporated into the material from which the vaso-occlusive device is formed. Any suitable radiopaque or MRI visible material may be employed.
Suitable materials for providing radiopacity to the device include, but are not limited to, platinum, rhodium, palladium, rhenium, iridium, tantalum, tungsten, gold, silver, alloys of these metals, as well as polymeric materials with barium, for example. Radiopacity is desirable for visualization of the device for purposes of positioning the device at the site of the defect and to position inside the defect and for proper anchoring of the device.
The invention is further directed to the combination of a vaso- occlusive device having at least one securement member and a stent, where the at least one securement member is secured to the stent. Also, the invention is directed to the combination of a delivery catheter and a vaso-occlusive device having at least one securement member.
The invention is further directed to a method of occluding a vascular defect having an opening. The method comprises the steps of: a) deploying a support structure, as discussed above, to the vascular defect, the support structure having an opening for accepting a vaso-occlusive device; b) deploying a vaso-occlusive device having at least one occlusive member having an expanded configuration and an unexpanded configuration, as discussed above and at least one securement member, as discussed above, through the opening of the support structure and through the opening of the vascular defect into the vascular defect; c) expanding the at least one occlusive member; and d) anchoring the vaso-occlusive device to the support structure with the at least one securement member.
The invention is also directed to a method of closing and occluding an opening of an aneurysm from a parent blood vessel. The method comprises the steps of: a) deploying a support structure, as discussed above, at the site of the aneurysm, the support structure having at least one opening for accepting a vaso- occlusive device as discussed above, the vaso-occlusive device having at least one occlusive member which has an unexpanded configuration and an expanded configuration and at least one securement member, the support structure positioned at the opening of the aneurysm such that the at least one opening of the support structure is aligned with the opening of the aneurysm; b) deploying the vaso-occlusive device wherein the at least one occlusive member is in its unexpanded configuration, through the at least one opening of the support structure and the opening of the aneurysm and into the aneurysm; c) expanding the at least one occlusive member of the vaso-occlusive device to its expanded state whereby the vaso-occlusive device blocks the opening of the aneurysm from the parent blood vessel in its expanded state; and d) anchoring the vaso-occlusive device to the support structure with the at least one securement member.
The above disclosure is intended for illustrative purposes only and is not exhaustive. The embodiments described therein will suggest many variations and alternatives to one of ordinary skill in this art. All these alternatives and variations are intended to be included within the scope of the attached claims. Those familiar with the art may recognize other equivalents to the specific embodiments described herein which equivalents are also intended to be encompassed by the claims attached hereto.

Claims

1. A device for the treatment of a vascular defect, said device comprising: at least one occlusive member having a first unexpanded configuration and a second expanded configuration; and at least one securement member for securing said device to a support structure at the location of the vascular defect.
2. The device of Claim 1 wherein said support structure is a stent or stent/graft.
3. The device of Claim 2 wherein said support structure is a stent of the self- expanding variety.
4. The device of Claim 1 wherein said at least one securement member, said at least one occlusive member, or both, are comprised of a metal or metal alloy.
5. The device of Claim 4 wherein said metal is a shape memory metal.
6. The device of Claim 1 wherein said at least one occlusive member, said at least one securement member, or both, are formed from a polymeric material.
7. The device of Claim 1 wherein said at least one occlusive member, at least one securement member, or both, are formed from a biologically derived material.
8. The device of Claim 1 wherein said occlusive member is formed from a biologically derived material.
9. The device of Claim 8 wherein said biologically derived material is selected from the group consisting of collagen foams, harvested vascular material, processed tissues and combinations thereof.
10. The device of Claim 1 wherein said at least one occlusive member is formed from a combination of at least one polymeric material and at least one metal or metal alloy.
11. The device of Claim 10 wherein said at least one occlusive member is in the form of an umbrella, parabola, sphere or disc.
12. The device of Claim 6 wherein said polymeric material is selected from the group consisting of polyurethanes, polyolefins, polyesters, polyamides, fluoropolymers, silicones, acrylics, polypeptides, and mixtures thereof.
13. The device of Claim 6 wherein said polymeric material is a swellable polymeric material.
14. The device of Claim 13 wherein said swellable polymeric material is a hydrogel.
15. The device of Claim 1 wherein said at least one securement member and at least one occlusive member are formed from a swellable polymeric material.
16. The device of Claim 1 wherein said at least one securement member swells in an aqueous environment.
17. The device of Claim 16 wherein said at least one securement member is formed from a hydrogel.
18. The device of Claim 1 wherein said at least one occlusive member and said at least one securement member are formed from a swellable polymeric material or a compressed foam.
19. The device of Claim 1 wherein at least a portion of said at least one occlusive member has a braided, woven, knit, felt-like or mesh configuration.
20. The device of Claim 1 wherein said at least one occlusive member blocks the flow of fluid to a defect in the vasculature.
21. The device of Claim 1 wherein said vascular defect is an arterial-venus fistula.
22. The device of Claim 1 wherein said vascular defect is an aneurysm.
23. The device of Claim 1 further in combination with a catheter.
24. The device of Claim 1 further comprising at least one radiopaque material.
25. The device of Claim 1 further comprising at least one bioactive material.
26. A vaso-occlusive device formed from a swellable material or a compressed foam, said vaso-occlusive device having at least one securement member.
27. The vaso-occlusive device of Claim 26 wherein said at least one occlusive member of said vaso-occlusive device is in the shape of an umbrella, parabola, sphere or disc.
28. A method of occluding a vascular defect having an opening, the method comprising the steps of: a) deploying a support structure to said vascular defect said support structure having an opening for accepting a vaso-occlusive device; b) deploying a vaso-occlusive device having at least one occlusive member having an expanded configuration and an unexpanded configuration and at least one securement member through said opening of said support structure and through said opening of said vascular defect into said vascular defect; and c) expanding said at least one occlusive member; and d) anchoring said vaso-occlusive device to said support structure with said at least one securement member.
29. The method of Claim 28 wherein said support structure is a stent or stent/graft having a plurality of struts.
30. The method of Claim 28 wherein said support structure is a straight or a bifurcated stent.
31. The method of Claim 30 wherein said support structure is a stent and said opening for accepting said vaso-occlusive device is formed between said struts.
32. The method of Claim 30 wherein said support structure is a stent of the self- expanding variety.
33. The method of Claim 28 wherein said at least one occlusive member is polymeric.
34. The method of Claim 28 wherein said at least one securement member is metallic or polymeric.
35. The method of Claim 34 wherein said at least one securement member is formed from more than one strut-like element.
36. The method of Claim 34 wherein said at least one securement member is formed from a shape memory material or superelastic material.
37. The method of Claim 34 wherein said at least one securement member is a swellable polymeric material.
38. The method of Claim 37 wherein said at least one securement member is a hydrogel.
39. The method of Claim 28 wherein said vaso-occlusive device is deployed with a microcatheter.
40. A method of closing and occluding an opening of an aneurysm from a parent blood vessel, the method comprising the steps of: a) deploying a support structure at the site of the aneurysm said support structure having at least one opening for accepting a vaso-occlusive device, said vaso-occlusive device having at least one occlusive member which has an unexpanded configuration and an expanded configuration and at least one securement member, said support structure positioned at said opening of said aneurysm such that said at least one opening of said support structure is aligned with said opening of said aneurysm; b) deploying said vaso-occlusive device wherein said at least one occlusive member is in its unexpanded configuration, through said at least one opening of said support structure and said opening of said aneurysm and into said aneurysm; c) expanding said at least one occlusive member of said vaso-occlusive device to its expanded state whereby said vaso-occlusive device blocks said opening of said aneurysm from said parent blood vessel in its expanded state; and d) anchoring said vaso-occlusive device to said support structure with said at least one securement member.
41. The method of Claim 40 wherein said support structure is a stent having a plurality of struts and said at least one opening is formed between said struts.
42. The method of Claim 40 wherein said stent is a self-expanding stent.
43. The method of Claim 40 wherein said vaso-occlusive device is deployed with a microcatheter.
44. In combination, a vaso-occlusive device having at least one securement member and a stent, the at least one securement member secured to the stent.
PCT/US2003/024764 2002-08-29 2003-07-29 Device for closure of a vascular defect and method for treating the same WO2004019791A2 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
AU2003256880A AU2003256880A1 (en) 2002-08-29 2003-07-29 Device for closure of a vascular defect and method for treating the same
EP03791657A EP1549229B1 (en) 2002-08-29 2003-07-29 Device for closure of a vascular defect
CA002485206A CA2485206A1 (en) 2002-08-29 2003-07-29 Device for closure of a vascular defect and method for treating the same
JP2004532875A JP4472525B2 (en) 2002-08-29 2003-07-29 Embolizer for vascular lesions
DE60326474T DE60326474D1 (en) 2002-08-29 2003-07-29 DEVICE FOR CLOSING A VASCULAR DEFECT

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/230,803 2002-08-29
US10/230,803 US20040044391A1 (en) 2002-08-29 2002-08-29 Device for closure of a vascular defect and method of treating the same

Publications (2)

Publication Number Publication Date
WO2004019791A2 true WO2004019791A2 (en) 2004-03-11
WO2004019791A3 WO2004019791A3 (en) 2004-06-24

Family

ID=31976586

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2003/024764 WO2004019791A2 (en) 2002-08-29 2003-07-29 Device for closure of a vascular defect and method for treating the same

Country Status (8)

Country Link
US (3) US20040044391A1 (en)
EP (1) EP1549229B1 (en)
JP (1) JP4472525B2 (en)
AT (1) ATE424149T1 (en)
AU (1) AU2003256880A1 (en)
CA (1) CA2485206A1 (en)
DE (1) DE60326474D1 (en)
WO (1) WO2004019791A2 (en)

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005035020A2 (en) 2003-10-07 2005-04-21 Henry Ford Health System Platform catheter
WO2006034166A2 (en) 2004-09-17 2006-03-30 Cordis Neurovascular, Inc. Thin film metallic devices for plugging aneurysms or vessels
US7794474B2 (en) 1996-08-22 2010-09-14 The Trustees Of Columbia University In The City Of New York Endovascular flexible stapling device
US7914527B2 (en) 2003-03-27 2011-03-29 Terumo Kabushiki Kaisha Energy based devices and methods for treatment of patent foramen ovale
US7922716B2 (en) 2003-03-27 2011-04-12 Terumo Kabushiki Kaisha Energy based devices and methods for treatment of anatomic tissue defects
US7972330B2 (en) 2003-03-27 2011-07-05 Terumo Kabushiki Kaisha Methods and apparatus for closing a layered tissue defect
US8021362B2 (en) 2003-03-27 2011-09-20 Terumo Kabushiki Kaisha Methods and apparatus for closing a layered tissue defect
US8038672B2 (en) 2003-03-27 2011-10-18 Terumo Kabushiki Kaisha Energy based devices and methods for treatment of patent foramen ovale
US8052678B2 (en) 2003-03-27 2011-11-08 Terumo Kabushiki Kaisha Energy based devices and methods for treatment of patent foramen ovale
US8057469B2 (en) 2003-03-27 2011-11-15 Terumo Kabushiki Kaisha Methods and apparatus for treatment of patent foramen ovale
US8109274B2 (en) 2005-04-11 2012-02-07 Terumo Kabushiki Kaisha Methods and electrode apparatus to achieve a closure of a layered tissue defect
US8133221B2 (en) 2004-06-21 2012-03-13 Terumo Kabushiki Kaisha Energy based devices and methods for treatment of anatomic tissue defects
US9498604B2 (en) 1997-11-12 2016-11-22 Genesis Technologies Llc Medical device and method
US9561094B2 (en) 2010-07-23 2017-02-07 Nfinium Vascular Technologies, Llc Devices and methods for treating venous diseases
US11266414B2 (en) 2014-06-04 2022-03-08 Vascular Development Corp, Llc Low radial force vascular device and method of occlusion

Families Citing this family (166)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6494916B1 (en) * 2001-07-30 2002-12-17 Biomed Solutions, Llc Apparatus for replacing musculo-skeletal parts
US6802851B2 (en) * 2001-09-20 2004-10-12 Gordia Neurovascular, Inc. Stent aneurysm embolization method using collapsible member and embolic coils
US20040044391A1 (en) 2002-08-29 2004-03-04 Stephen Porter Device for closure of a vascular defect and method of treating the same
CA2507649C (en) * 2003-04-02 2011-10-11 Mehran Bashiri Detachable and retrievable stent assembly
CA2525792C (en) 2003-05-15 2015-10-13 Biomerix Corporation Reticulated elastomeric matrices, their manufacture and use in implantable devices
US7763077B2 (en) 2003-12-24 2010-07-27 Biomerix Corporation Repair of spinal annular defects and annulo-nucleoplasty regeneration
US7608092B1 (en) 2004-02-20 2009-10-27 Biomet Sports Medicince, LLC Method and apparatus for performing meniscus repair
US8267985B2 (en) 2005-05-25 2012-09-18 Tyco Healthcare Group Lp System and method for delivering and deploying an occluding device within a vessel
US7749250B2 (en) 2006-02-03 2010-07-06 Biomet Sports Medicine, Llc Soft tissue repair assembly and associated method
US8088130B2 (en) 2006-02-03 2012-01-03 Biomet Sports Medicine, Llc Method and apparatus for coupling soft tissue to a bone
US7905904B2 (en) 2006-02-03 2011-03-15 Biomet Sports Medicine, Llc Soft tissue repair device and associated methods
US8840645B2 (en) 2004-11-05 2014-09-23 Biomet Sports Medicine, Llc Method and apparatus for coupling soft tissue to a bone
US9017381B2 (en) 2007-04-10 2015-04-28 Biomet Sports Medicine, Llc Adjustable knotless loops
US7909851B2 (en) 2006-02-03 2011-03-22 Biomet Sports Medicine, Llc Soft tissue repair device and associated methods
US8361113B2 (en) 2006-02-03 2013-01-29 Biomet Sports Medicine, Llc Method and apparatus for coupling soft tissue to a bone
US8298262B2 (en) 2006-02-03 2012-10-30 Biomet Sports Medicine, Llc Method for tissue fixation
US8128658B2 (en) 2004-11-05 2012-03-06 Biomet Sports Medicine, Llc Method and apparatus for coupling soft tissue to bone
US7857830B2 (en) * 2006-02-03 2010-12-28 Biomet Sports Medicine, Llc Soft tissue repair and conduit device
US8118836B2 (en) 2004-11-05 2012-02-21 Biomet Sports Medicine, Llc Method and apparatus for coupling soft tissue to a bone
US20060189993A1 (en) 2004-11-09 2006-08-24 Arthrotek, Inc. Soft tissue conduit device
US8303604B2 (en) 2004-11-05 2012-11-06 Biomet Sports Medicine, Llc Soft tissue repair device and method
US8137382B2 (en) 2004-11-05 2012-03-20 Biomet Sports Medicine, Llc Method and apparatus for coupling anatomical features
US7601165B2 (en) 2006-09-29 2009-10-13 Biomet Sports Medicine, Llc Method and apparatus for forming a self-locking adjustable suture loop
US9801708B2 (en) 2004-11-05 2017-10-31 Biomet Sports Medicine, Llc Method and apparatus for coupling soft tissue to a bone
US8998949B2 (en) 2004-11-09 2015-04-07 Biomet Sports Medicine, Llc Soft tissue conduit device
US20060106421A1 (en) * 2004-11-16 2006-05-18 Clifford Teoh Expansible neck bridge
WO2006096449A2 (en) * 2005-03-03 2006-09-14 Hines Richard A Endovascular aneurysm treatment device and delivery system
US20060206199A1 (en) * 2005-03-12 2006-09-14 Churchwell Stacey D Aneurysm treatment devices
US20060206198A1 (en) * 2005-03-12 2006-09-14 Churchwell Stacey D Aneurysm treatment devices and methods
JP4945714B2 (en) 2005-05-25 2012-06-06 タイコ ヘルスケア グループ リミテッド パートナーシップ System and method for supplying and deploying an occlusion device in a conduit
US8273101B2 (en) 2005-05-25 2012-09-25 Tyco Healthcare Group Lp System and method for delivering and deploying an occluding device within a vessel
BRPI0617652A2 (en) 2005-10-19 2011-08-02 Pulsar Vascular Inc methods and systems for endovascular incision and repair of tissue and lumen defects
US8652172B2 (en) 2006-02-03 2014-02-18 Biomet Sports Medicine, Llc Flexible anchors for tissue fixation
US8652171B2 (en) 2006-02-03 2014-02-18 Biomet Sports Medicine, Llc Method and apparatus for soft tissue fixation
US8506597B2 (en) 2011-10-25 2013-08-13 Biomet Sports Medicine, Llc Method and apparatus for interosseous membrane reconstruction
US8562645B2 (en) 2006-09-29 2013-10-22 Biomet Sports Medicine, Llc Method and apparatus for forming a self-locking adjustable loop
US9468433B2 (en) 2006-02-03 2016-10-18 Biomet Sports Medicine, Llc Method and apparatus for forming a self-locking adjustable loop
US8251998B2 (en) 2006-08-16 2012-08-28 Biomet Sports Medicine, Llc Chondral defect repair
US9271713B2 (en) 2006-02-03 2016-03-01 Biomet Sports Medicine, Llc Method and apparatus for tensioning a suture
US8562647B2 (en) 2006-09-29 2013-10-22 Biomet Sports Medicine, Llc Method and apparatus for securing soft tissue to bone
US8801783B2 (en) 2006-09-29 2014-08-12 Biomet Sports Medicine, Llc Prosthetic ligament system for knee joint
US8771352B2 (en) 2011-05-17 2014-07-08 Biomet Sports Medicine, Llc Method and apparatus for tibial fixation of an ACL graft
US8574235B2 (en) 2006-02-03 2013-11-05 Biomet Sports Medicine, Llc Method for trochanteric reattachment
US10517587B2 (en) 2006-02-03 2019-12-31 Biomet Sports Medicine, Llc Method and apparatus for forming a self-locking adjustable loop
US9149267B2 (en) 2006-02-03 2015-10-06 Biomet Sports Medicine, Llc Method and apparatus for coupling soft tissue to a bone
US8968364B2 (en) 2006-02-03 2015-03-03 Biomet Sports Medicine, Llc Method and apparatus for fixation of an ACL graft
US8597327B2 (en) 2006-02-03 2013-12-03 Biomet Manufacturing, Llc Method and apparatus for sternal closure
US9078644B2 (en) 2006-09-29 2015-07-14 Biomet Sports Medicine, Llc Fracture fixation device
US11259792B2 (en) 2006-02-03 2022-03-01 Biomet Sports Medicine, Llc Method and apparatus for coupling anatomical features
US7959650B2 (en) 2006-09-29 2011-06-14 Biomet Sports Medicine, Llc Adjustable knotless loops
US11311287B2 (en) 2006-02-03 2022-04-26 Biomet Sports Medicine, Llc Method for tissue fixation
US9538998B2 (en) 2006-02-03 2017-01-10 Biomet Sports Medicine, Llc Method and apparatus for fracture fixation
WO2007134266A2 (en) 2006-05-12 2007-11-22 Electroformed Stents, Inc. Exclusion device and system for delivery
JP2010500915A (en) * 2006-08-17 2010-01-14 エヌフォーカス ニューロメディカル, インコーポレイテッド Aneurysm isolation device
US9918826B2 (en) 2006-09-29 2018-03-20 Biomet Sports Medicine, Llc Scaffold for spring ligament repair
US11259794B2 (en) 2006-09-29 2022-03-01 Biomet Sports Medicine, Llc Method for implanting soft tissue
US8500818B2 (en) 2006-09-29 2013-08-06 Biomet Manufacturing, Llc Knee prosthesis assembly with ligament link
US8672969B2 (en) 2006-09-29 2014-03-18 Biomet Sports Medicine, Llc Fracture fixation device
WO2008058019A2 (en) * 2006-11-02 2008-05-15 Pakbaz R Sean Devices and methods for accessing and treating an aneurysm
WO2008063455A1 (en) * 2006-11-13 2008-05-29 Hines Richard A Over-the wire exclusion device and system for delivery
WO2008118896A1 (en) * 2007-03-26 2008-10-02 Dynamic Flowform Corp. Proximally self-locking long bone prosthesis
US9034007B2 (en) * 2007-09-21 2015-05-19 Insera Therapeutics, Inc. Distal embolic protection devices with a variable thickness microguidewire and methods for their use
US20100076463A1 (en) * 2008-04-04 2010-03-25 Akshay Mavani Implantable fistula closure device
EP3970633A1 (en) 2008-04-21 2022-03-23 Covidien LP Braid-ball embolic devices and delivery systems
US10716573B2 (en) 2008-05-01 2020-07-21 Aneuclose Janjua aneurysm net with a resilient neck-bridging portion for occluding a cerebral aneurysm
US10028747B2 (en) 2008-05-01 2018-07-24 Aneuclose Llc Coils with a series of proximally-and-distally-connected loops for occluding a cerebral aneurysm
US9675482B2 (en) 2008-05-13 2017-06-13 Covidien Lp Braid implant delivery systems
CN102137626A (en) * 2008-07-22 2011-07-27 微治疗公司 Vascular remodeling device
EP2316047B1 (en) * 2008-08-18 2011-12-07 Qioptiq Photonics GmbH & Co. KG Method for producing a lens
AU2009289474B2 (en) * 2008-09-04 2015-09-03 Curaseal Inc. Inflatable devices for enteric fistula treatment
ES2879278T3 (en) 2008-09-05 2021-11-22 Pulsar Vascular Inc Systems to support or occlude a physiological opening or cavity
US20100069948A1 (en) * 2008-09-12 2010-03-18 Micrus Endovascular Corporation Self-expandable aneurysm filling device, system and method of placement
WO2010048177A2 (en) * 2008-10-20 2010-04-29 IMDS, Inc. Systems and methods for aneurysm treatment and vessel occlusion
US8343227B2 (en) 2009-05-28 2013-01-01 Biomet Manufacturing Corp. Knee prosthesis assembly with ligament link
WO2011003147A1 (en) * 2009-07-09 2011-01-13 Murray Vascular Pty Limited A support device for a tubular structure
JP5731512B2 (en) 2009-09-04 2015-06-10 パルサー バスキュラー インコーポレイテッド System and method for sealing an anatomical opening
US20110202085A1 (en) * 2009-11-09 2011-08-18 Siddharth Loganathan Braid Ball Embolic Device Features
US9358140B1 (en) 2009-11-18 2016-06-07 Aneuclose Llc Stent with outer member to embolize an aneurysm
CN102740799A (en) * 2010-01-28 2012-10-17 泰科保健集团有限合伙公司 Vascular remodeling device
EP2528541B1 (en) * 2010-01-28 2016-05-18 Covidien LP Vascular remodeling device
US8728067B2 (en) * 2010-03-08 2014-05-20 Covidien Lp Microwave antenna probe having a deployable ground plane
US8425548B2 (en) 2010-07-01 2013-04-23 Aneaclose LLC Occluding member expansion and then stent expansion for aneurysm treatment
AU2012214240B2 (en) 2011-02-11 2015-03-12 Covidien Lp Two-stage deployment aneurysm embolization devices
US20120245674A1 (en) 2011-03-25 2012-09-27 Tyco Healthcare Group Lp Vascular remodeling device
US10004510B2 (en) 2011-06-03 2018-06-26 Pulsar Vascular, Inc. Systems and methods for enclosing an anatomical opening, including shock absorbing aneurysm devices
ES2656328T3 (en) 2011-06-03 2018-02-26 Pulsar Vascular, Inc. Aneurism devices with additional anchoring mechanisms and associated systems
WO2012174469A2 (en) 2011-06-16 2012-12-20 Curaseal Inc. Fistula treatment devices and related methods
EP2720623A4 (en) 2011-06-17 2015-04-22 Curaseal Inc Fistula treatment devices and methods
CN102379731B (en) * 2011-08-03 2014-02-19 北京华医圣杰科技有限公司 Aortic aneurysm dissection stent system and preparation method thereof
WO2013049448A1 (en) 2011-09-29 2013-04-04 Covidien Lp Vascular remodeling device
EP3735916A1 (en) 2011-10-05 2020-11-11 Pulsar Vascular, Inc. Devices for enclosing an anatomical opening
US9357991B2 (en) 2011-11-03 2016-06-07 Biomet Sports Medicine, Llc Method and apparatus for stitching tendons
US9314241B2 (en) 2011-11-10 2016-04-19 Biomet Sports Medicine, Llc Apparatus for coupling soft tissue to a bone
US9370350B2 (en) 2011-11-10 2016-06-21 Biomet Sports Medicine, Llc Apparatus for coupling soft tissue to a bone
US9381013B2 (en) 2011-11-10 2016-07-05 Biomet Sports Medicine, Llc Method for coupling soft tissue to a bone
US9597223B2 (en) * 2012-05-23 2017-03-21 Nandhika Wijay Reversible acute occlusion implant, delivery catheter and method
US9155647B2 (en) 2012-07-18 2015-10-13 Covidien Lp Methods and apparatus for luminal stenting
US9314248B2 (en) 2012-11-06 2016-04-19 Covidien Lp Multi-pivot thrombectomy device
CN104918565B (en) 2012-11-13 2018-04-27 柯惠有限合伙公司 plugging device
US20140180377A1 (en) * 2012-12-20 2014-06-26 Penumbra, Inc. Aneurysm occlusion system and method
US9295571B2 (en) 2013-01-17 2016-03-29 Covidien Lp Methods and apparatus for luminal stenting
US9757119B2 (en) 2013-03-08 2017-09-12 Biomet Sports Medicine, Llc Visual aid for identifying suture limbs arthroscopically
US9339274B2 (en) * 2013-03-12 2016-05-17 St. Jude Medical, Cardiology Division, Inc. Paravalvular leak occlusion device for self-expanding heart valves
US10271949B2 (en) 2013-03-12 2019-04-30 St. Jude Medical, Cardiology Division, Inc. Paravalvular leak occlusion device for self-expanding heart valves
US9463105B2 (en) 2013-03-14 2016-10-11 Covidien Lp Methods and apparatus for luminal stenting
US9918827B2 (en) 2013-03-14 2018-03-20 Biomet Sports Medicine, Llc Scaffold for spring ligament repair
US8715314B1 (en) 2013-03-15 2014-05-06 Insera Therapeutics, Inc. Vascular treatment measurement methods
CN105142545B (en) 2013-03-15 2018-04-06 柯惠有限合伙公司 Locking device
WO2014150288A2 (en) 2013-03-15 2014-09-25 Insera Therapeutics, Inc. Vascular treatment devices and methods
US8715315B1 (en) 2013-03-15 2014-05-06 Insera Therapeutics, Inc. Vascular treatment systems
US8679150B1 (en) 2013-03-15 2014-03-25 Insera Therapeutics, Inc. Shape-set textile structure based mechanical thrombectomy methods
US9907684B2 (en) 2013-05-08 2018-03-06 Aneuclose Llc Method of radially-asymmetric stent expansion
US9681876B2 (en) 2013-07-31 2017-06-20 EMBA Medical Limited Methods and devices for endovascular embolization
US10010328B2 (en) 2013-07-31 2018-07-03 NeuVT Limited Endovascular occlusion device with hemodynamically enhanced sealing and anchoring
US10136886B2 (en) 2013-12-20 2018-11-27 Biomet Sports Medicine, Llc Knotless soft tissue devices and techniques
US11076860B2 (en) 2014-03-31 2021-08-03 DePuy Synthes Products, Inc. Aneurysm occlusion device
US11154302B2 (en) 2014-03-31 2021-10-26 DePuy Synthes Products, Inc. Aneurysm occlusion device
CN106456183B (en) * 2014-04-30 2019-09-20 Cerus血管内设备有限公司 Locking device
US9615822B2 (en) 2014-05-30 2017-04-11 Biomet Sports Medicine, Llc Insertion tools and method for soft anchor
US9700291B2 (en) 2014-06-03 2017-07-11 Biomet Sports Medicine, Llc Capsule retractor
US10039543B2 (en) 2014-08-22 2018-08-07 Biomet Sports Medicine, Llc Non-sliding soft anchor
US10595875B2 (en) 2014-12-31 2020-03-24 Endostream Medical Ltd. Device for restricting blood flow to aneurysms
US9955980B2 (en) 2015-02-24 2018-05-01 Biomet Sports Medicine, Llc Anatomic soft tissue repair
WO2016137997A1 (en) 2015-02-25 2016-09-01 Galaxy Therapeutics, Llc System for and method of treating aneurysms
JP6875282B2 (en) * 2015-03-26 2021-05-19 ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. System for treating patients
US9974534B2 (en) 2015-03-31 2018-05-22 Biomet Sports Medicine, Llc Suture anchor with soft anchor of electrospun fibers
US10478194B2 (en) 2015-09-23 2019-11-19 Covidien Lp Occlusive devices
CA3005686A1 (en) 2015-12-07 2017-06-15 Cerus Endovascular Limited Occlusion device
EP3416568A4 (en) 2016-02-16 2019-10-16 Insera Therapeutics, Inc. Aspiration devices and anchored flow diverting devices
CA3016679A1 (en) 2016-03-11 2017-09-14 Cerus Endovascular Limited Occlusion device
CN105902291A (en) * 2016-04-08 2016-08-31 张小曦 Intracranial aneurysm interventional closure treatment device
WO2017200866A1 (en) 2016-05-17 2017-11-23 The Cleveland Clinic Foundation Apparatus for blocking bloodflow through a dissected aorta
EP3471660B1 (en) 2016-06-21 2021-07-28 Endostream Medical Ltd. Medical device for treating vascular malformations
KR20190115474A (en) * 2017-02-23 2019-10-11 디퍼이 신테스 프로덕츠, 인코포레이티드 Aneurysm device and delivery system
MX2020001999A (en) 2017-08-21 2020-07-20 Cerus Endovascular Ltd Occlusion device.
FR3072558B1 (en) * 2017-10-23 2021-11-26 Stsat Ag SYSTEM FOR PLUGGING AN ANEVRISM
CN110612072A (en) * 2017-12-21 2019-12-24 得克萨斯农业及机械体系综合大学 Vascular prosthesis for leak protection in endovascular aneurysm repair
US10716574B2 (en) * 2017-12-22 2020-07-21 DePuy Synthes Products, Inc. Aneurysm device and delivery method
US10751065B2 (en) 2017-12-22 2020-08-25 DePuy Synthes Products, Inc. Aneurysm device and delivery system
US11185335B2 (en) 2018-01-19 2021-11-30 Galaxy Therapeutics Inc. System for and method of treating aneurysms
US10905430B2 (en) 2018-01-24 2021-02-02 DePuy Synthes Products, Inc. Aneurysm device and delivery system
US10258284B1 (en) * 2018-04-05 2019-04-16 Tufts Medical Center, Inc. Implant in middle meningial-artery
US11596412B2 (en) 2018-05-25 2023-03-07 DePuy Synthes Products, Inc. Aneurysm device and delivery system
US11058430B2 (en) 2018-05-25 2021-07-13 DePuy Synthes Products, Inc. Aneurysm device and delivery system
US10939915B2 (en) 2018-05-31 2021-03-09 DePuy Synthes Products, Inc. Aneurysm device and delivery system
US11051825B2 (en) 2018-08-08 2021-07-06 DePuy Synthes Products, Inc. Delivery system for embolic braid
US11123077B2 (en) 2018-09-25 2021-09-21 DePuy Synthes Products, Inc. Intrasaccular device positioning and deployment system
US11076861B2 (en) 2018-10-12 2021-08-03 DePuy Synthes Products, Inc. Folded aneurysm treatment device and delivery method
US11406392B2 (en) * 2018-12-12 2022-08-09 DePuy Synthes Products, Inc. Aneurysm occluding device for use with coagulating agents
US11272939B2 (en) 2018-12-18 2022-03-15 DePuy Synthes Products, Inc. Intrasaccular flow diverter for treating cerebral aneurysms
CN113260323A (en) 2019-01-17 2021-08-13 内流医疗有限公司 Vascular malformation implant system
US11134953B2 (en) 2019-02-06 2021-10-05 DePuy Synthes Products, Inc. Adhesive cover occluding device for aneurysm treatment
US11337706B2 (en) 2019-03-27 2022-05-24 DePuy Synthes Products, Inc. Aneurysm treatment device
US11278292B2 (en) 2019-05-21 2022-03-22 DePuy Synthes Products, Inc. Inverting braided aneurysm treatment system and method
US11497504B2 (en) 2019-05-21 2022-11-15 DePuy Synthes Products, Inc. Aneurysm treatment with pushable implanted braid
US11672542B2 (en) 2019-05-21 2023-06-13 DePuy Synthes Products, Inc. Aneurysm treatment with pushable ball segment
US10653425B1 (en) 2019-05-21 2020-05-19 DePuy Synthes Products, Inc. Layered braided aneurysm treatment device
US11413046B2 (en) 2019-05-21 2022-08-16 DePuy Synthes Products, Inc. Layered braided aneurysm treatment device
US11607226B2 (en) 2019-05-21 2023-03-21 DePuy Synthes Products, Inc. Layered braided aneurysm treatment device with corrugations
US11602350B2 (en) 2019-12-05 2023-03-14 DePuy Synthes Products, Inc. Intrasaccular inverting braid with highly flexible fill material
US11166731B2 (en) 2019-05-25 2021-11-09 Galaxy Therapeutics Inc. Systems and methods for treating aneurysms
CN114630627A (en) 2019-11-04 2022-06-14 柯惠有限合伙公司 Devices, systems, and methods for treating intracranial aneurysms
US11457926B2 (en) 2019-12-18 2022-10-04 DePuy Synthes Products, Inc. Implant having an intrasaccular section and intravascular section
CN113017746A (en) * 2019-12-24 2021-06-25 上海微创心脉医疗科技(集团)股份有限公司 Interlayer crevasse plugging system
CN113017745A (en) * 2019-12-24 2021-06-25 上海微创心脉医疗科技(集团)股份有限公司 Plugging device and system
US11406404B2 (en) 2020-02-20 2022-08-09 Cerus Endovascular Limited Clot removal distal protection methods

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2678508A1 (en) * 1991-07-04 1993-01-08 Celsa Lg Device for reinforcing the vessels of the human body
US5980514A (en) * 1996-07-26 1999-11-09 Target Therapeutics, Inc. Aneurysm closure device assembly
US6063070A (en) * 1997-08-05 2000-05-16 Target Therapeutics, Inc. Detachable aneurysm neck bridge (II)
US6093199A (en) * 1998-08-05 2000-07-25 Endovascular Technologies, Inc. Intra-luminal device for treatment of body cavities and lumens and method of use
US6165193A (en) * 1998-07-06 2000-12-26 Microvention, Inc. Vascular embolization with an expansible implant
US6168622B1 (en) * 1996-01-24 2001-01-02 Microvena Corporation Method and apparatus for occluding aneurysms
WO2001030267A1 (en) * 1999-10-27 2001-05-03 Atritech, Inc. Barrier device for covering the ostium of left atrial appendage
US20030055440A1 (en) * 2001-09-20 2003-03-20 Jones Donald K. Stent aneurysm embolization method using collapsible member and embolic coils

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5506300A (en) * 1985-01-04 1996-04-09 Thoratec Laboratories Corporation Compositions that soften at predetermined temperatures and the method of making same
JP2502132B2 (en) * 1988-09-30 1996-05-29 三菱重工業株式会社 Shape memory polyurethane elastomer molded body
US5122136A (en) * 1990-03-13 1992-06-16 The Regents Of The University Of California Endovascular electrolytically detachable guidewire tip for the electroformation of thrombus in arteries, veins, aneurysms, vascular malformations and arteriovenous fistulas
US5354295A (en) * 1990-03-13 1994-10-11 Target Therapeutics, Inc. In an endovascular electrolytically detachable wire and tip for the formation of thrombus in arteries, veins, aneurysms, vascular malformations and arteriovenous fistulas
US6083220A (en) * 1990-03-13 2000-07-04 The Regents Of The University Of California Endovascular electrolytically detachable wire and tip for the formation of thrombus in arteries, veins, aneurysms, vascular malformations and arteriovenous fistulas
US5665822A (en) * 1991-10-07 1997-09-09 Landec Corporation Thermoplastic Elastomers
US5750585A (en) * 1995-04-04 1998-05-12 Purdue Research Foundation Super absorbent hydrogel foams
EP1723931B1 (en) * 1996-11-04 2012-01-04 Advanced Stent Technologies, Inc. Extendible stent apparatus and method for deploying the same
US6036720A (en) * 1997-12-15 2000-03-14 Target Therapeutics, Inc. Sheet metal aneurysm neck bridge
DK1062278T3 (en) * 1998-02-23 2006-09-25 Mnemoscience Gmbh Polymers with shape memory
US6063111A (en) * 1998-03-31 2000-05-16 Cordis Corporation Stent aneurysm treatment system and method
US6113629A (en) * 1998-05-01 2000-09-05 Micrus Corporation Hydrogel for the therapeutic treatment of aneurysms
US6139564A (en) * 1998-06-16 2000-10-31 Target Therapeutics Inc. Minimally occlusive flow disruptor stent for bridging aneurysm necks
US5935148A (en) * 1998-06-24 1999-08-10 Target Therapeutics, Inc. Detachable, varying flexibility, aneurysm neck bridge
US6238403B1 (en) * 1999-10-04 2001-05-29 Microvention, Inc. Filamentous embolic device with expansible elements
US6602261B2 (en) * 1999-10-04 2003-08-05 Microvention, Inc. Filamentous embolic device with expansile elements
US6790218B2 (en) * 1999-12-23 2004-09-14 Swaminathan Jayaraman Occlusive coil manufacture and delivery
AU2001279261A1 (en) 2000-06-23 2002-01-08 John J Frantzen Radially expandable aneurysm treatment stent
FR2822370B1 (en) * 2001-03-23 2004-03-05 Perouse Lab TUBULAR ENDOPROSTHESIS COMPRISING A DEFORMABLE RING AND REQUIRED OF INTERVENTION FOR ITS IMPLANTATION
US6811560B2 (en) * 2001-09-20 2004-11-02 Cordis Neurovascular, Inc. Stent aneurysm embolization method and device
US20040044391A1 (en) 2002-08-29 2004-03-04 Stephen Porter Device for closure of a vascular defect and method of treating the same

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2678508A1 (en) * 1991-07-04 1993-01-08 Celsa Lg Device for reinforcing the vessels of the human body
US6168622B1 (en) * 1996-01-24 2001-01-02 Microvena Corporation Method and apparatus for occluding aneurysms
US5980514A (en) * 1996-07-26 1999-11-09 Target Therapeutics, Inc. Aneurysm closure device assembly
US6063070A (en) * 1997-08-05 2000-05-16 Target Therapeutics, Inc. Detachable aneurysm neck bridge (II)
US6165193A (en) * 1998-07-06 2000-12-26 Microvention, Inc. Vascular embolization with an expansible implant
US6093199A (en) * 1998-08-05 2000-07-25 Endovascular Technologies, Inc. Intra-luminal device for treatment of body cavities and lumens and method of use
WO2001030267A1 (en) * 1999-10-27 2001-05-03 Atritech, Inc. Barrier device for covering the ostium of left atrial appendage
US20030055440A1 (en) * 2001-09-20 2003-03-20 Jones Donald K. Stent aneurysm embolization method using collapsible member and embolic coils

Cited By (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8048110B2 (en) 1996-08-22 2011-11-01 The Trustees Of Columbia University In The City Of New York Endovascular flexible stapling device
US9468437B2 (en) 1996-08-22 2016-10-18 The Trustees Of Columbia University In The City Of New York Endovascular flexible stapling device
US8167905B2 (en) 1996-08-22 2012-05-01 The Trustees Of Columbia University In The City Of New York Endovascular flexible stapling device
US7794474B2 (en) 1996-08-22 2010-09-14 The Trustees Of Columbia University In The City Of New York Endovascular flexible stapling device
US9498604B2 (en) 1997-11-12 2016-11-22 Genesis Technologies Llc Medical device and method
US7972330B2 (en) 2003-03-27 2011-07-05 Terumo Kabushiki Kaisha Methods and apparatus for closing a layered tissue defect
US8066701B2 (en) 2003-03-27 2011-11-29 Terumo Kabushiki Kaisha Energy based devices and methods for treatment of patent foramen ovale
US8852181B2 (en) 2003-03-27 2014-10-07 Terumo Kabushiki Kaisha Energy based devices and methods for treatment of anatomic tissue defects
US8021362B2 (en) 2003-03-27 2011-09-20 Terumo Kabushiki Kaisha Methods and apparatus for closing a layered tissue defect
US8038673B2 (en) 2003-03-27 2011-10-18 Terumo Kabushiki Kaisha Energy based devices and methods for treatment of patent foramen ovale
US8038671B2 (en) 2003-03-27 2011-10-18 Terumo Kabushiki Kaisha Energy based devices and methods for treatment of patent foramen ovale
US8038672B2 (en) 2003-03-27 2011-10-18 Terumo Kabushiki Kaisha Energy based devices and methods for treatment of patent foramen ovale
US8038669B2 (en) 2003-03-27 2011-10-18 Terumo Kabushiki Kaisha Energy based devices and methods for treatment of patent foramen ovale
US7914527B2 (en) 2003-03-27 2011-03-29 Terumo Kabushiki Kaisha Energy based devices and methods for treatment of patent foramen ovale
US8052678B2 (en) 2003-03-27 2011-11-08 Terumo Kabushiki Kaisha Energy based devices and methods for treatment of patent foramen ovale
US8057469B2 (en) 2003-03-27 2011-11-15 Terumo Kabushiki Kaisha Methods and apparatus for treatment of patent foramen ovale
US7922716B2 (en) 2003-03-27 2011-04-12 Terumo Kabushiki Kaisha Energy based devices and methods for treatment of anatomic tissue defects
US8070747B2 (en) 2003-03-27 2011-12-06 Terumo Kabushiki Kaisha Energy based devices and methods for treatment of patent foramen ovale
US8075554B2 (en) 2003-03-27 2011-12-13 Terumo Kabushiki Kaisha Energy based devices and methods for treatment of patent foramen ovale
WO2005035020A2 (en) 2003-10-07 2005-04-21 Henry Ford Health System Platform catheter
US8133221B2 (en) 2004-06-21 2012-03-13 Terumo Kabushiki Kaisha Energy based devices and methods for treatment of anatomic tissue defects
EP1789123A4 (en) * 2004-09-17 2010-03-03 Cordis Neurovascular Inc Thin film metallic devices for plugging aneurysms or vessels
EP2468349A1 (en) * 2004-09-17 2012-06-27 Codman & Shurtleff, Inc. Thin film metallic devices for plugging aneurysms or vessels
EP2468348A1 (en) * 2004-09-17 2012-06-27 Codman & Shurtleff, Inc. Thin film metallic devices for plugging aneurysms or vessels
EP1789123A2 (en) * 2004-09-17 2007-05-30 Cordis Development Corporation Thin film metallic devices for plugging aneurysms or vessels
WO2006034166A2 (en) 2004-09-17 2006-03-30 Cordis Neurovascular, Inc. Thin film metallic devices for plugging aneurysms or vessels
US8109274B2 (en) 2005-04-11 2012-02-07 Terumo Kabushiki Kaisha Methods and electrode apparatus to achieve a closure of a layered tissue defect
US9561094B2 (en) 2010-07-23 2017-02-07 Nfinium Vascular Technologies, Llc Devices and methods for treating venous diseases
US11266414B2 (en) 2014-06-04 2022-03-08 Vascular Development Corp, Llc Low radial force vascular device and method of occlusion

Also Published As

Publication number Publication date
US8747430B2 (en) 2014-06-10
EP1549229A2 (en) 2005-07-06
US20040044391A1 (en) 2004-03-04
EP1549229B1 (en) 2009-03-04
JP2005537092A (en) 2005-12-08
JP4472525B2 (en) 2010-06-02
ATE424149T1 (en) 2009-03-15
DE60326474D1 (en) 2009-04-16
CA2485206A1 (en) 2004-03-11
US20050251200A1 (en) 2005-11-10
WO2004019791A3 (en) 2004-06-24
US8444667B2 (en) 2013-05-21
AU2003256880A1 (en) 2004-03-19
US20060206196A1 (en) 2006-09-14

Similar Documents

Publication Publication Date Title
EP1549229B1 (en) Device for closure of a vascular defect
US11291453B2 (en) Filamentary devices having a flexible joint for treatment of vascular defects
US8075585B2 (en) Device and method for treatment of a vascular defect
US20230149022A1 (en) Filamentary devices for treatment of vascular defects
EP2314231B1 (en) Aneurysm treatment device
US9962164B2 (en) Wing bifurcation reconstruction device
US6007573A (en) Intracranial stent and method of use
US20150209133A1 (en) Vascular remodeling device
AU2002316320A1 (en) Aneurysm treatment device
AU2019222964A1 (en) Improved aneurysm occlusion device
US20210346032A1 (en) Devices for treatment of vascular defects
US20210007754A1 (en) Filamentary devices for treatment of vascular defects
WO1999012484A1 (en) Vessel occlusion device
US20230363763A1 (en) Multiple layer devices for treatment of vascular defects
CN117414231A (en) Controllable self-expanding tectorial membrane support

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2485206

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2004532875

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 2003791657

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2003791657

Country of ref document: EP